Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks.

The pharmacogenomics journal - 1 Apr 2011

Roukos D H

Abstract excerpt

Life diversity can now be clearly explored with the next-generation DNA sequencing technology, allowing the discovery of genetic variants among individuals, patients and tumors. However, beyond causal mutations catalog completion, systems medicine is essential to link genotype to phenotypic cance...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Antibodies, Monoclonal, Humanized
Share to Antineoplastic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Regulatory Networks

Share to Genome, Human

Share to Precision Medicine

Share to Stomach Neoplasms

Share to Trastuzumab

Source

Identifiers

PMID: 20975737
DOI: 10.1038/tpj.2010.81

Genes

BRCA1
CDH1
EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20975737-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks.PMID 20975737Read ↗

Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.Semantic proximity Read ↗

Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data.Semantic proximity Read ↗

Conquering the challenges of genotypic and phenotypic tumor heterogeneity to realize the promise of personalized cancer therapy: the role of academia.Semantic proximity Read ↗

Polygenic and Network-based studies in risk identification and demystification of cancer.Semantic proximity Read ↗

Whole genome sequencing of breast cancerSemantic proximity Read ↗

[Personalized medicine and breast cancer: anticipatory medicine, prognostic evaluation and therapeutic targeting].Semantic proximity Read ↗

Combinatorial analysis of gene regulatory network reveals the causal genetic basis of breast cancer and gene-specific personalized drug treatmentsSemantic proximity Read ↗

[Genomics medicine and oncology].Semantic proximity Read ↗

Future of personalized medicine in oncology: a systems biology approach.Semantic proximity Read ↗

Mutated Pathways as a Guide to Adjuvant Therapy Treatments for Breast Cancer.Semantic proximity Read ↗

Copy number networks to guide combinatorial therapy for cancer and other disordersSemantic proximity Read ↗

Genetic heterogeneity in breast cancer: the road to personalized medicine?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.